Recruiting

Observational Study

Sponsor:

National Jewish Health

Code:

NCT03035097

Conditions

Bronchiolitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biorepository

Study Details

Brief summary:

The purpose of this research study is to establish a research database and biorepository for patients at National Jewish Health (NJH) who served in Operation Iraqi Freedom (OIF) or Operation Enduring Freedom (OEF). This study will also include civilian contractors who worked as part of these military operations in Iraq or Afghanistan. The biorepository would store blood samples obtained from these patients during a clinic visit. The research database would store prospectively and retrospectively collected clinical and exposure data that would enable us to comprehensively characterize each case.

Conditions

Bronchiolitis

Study ID

NCT03035097

Start date

Feb, 2013

Status verified date

Apr, 2026

Completion date

Dec, 2030

Anticipated

Primary completion date

Dec, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Served in the southwest Asia wars

Exclusion Criteria:

  • Did not served in the southwest Asia wars

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Interventions

Biorepository

One-time blood draw for blood to be stored in a biorepositoy

Primary outcome measure

  • collect symptom and exposure data [ Time Frame: Up to 24 months ]

Central Contacts and Locations

Central contacts

Lauren Zell-Baran, PhD, MPH

303-398-1187zell-baranl@njhealth.org

Locations

National Jewish Health

Recruiting

Denver, Colorado, United States, 80206

Contacts

Lauren Zell-Baran, PhD, MPH

303-398-1187zell-baranl@njhealth.org

More Information

Sponsor

National Jewish Health

Last update posted

Apr 15, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Jewish Health on 2026-04-15.